Allied Healthcare Products, Inc. (AHPI) Downgraded to Sell at ValuEngine
ValuEngine lowered shares of Allied Healthcare Products, Inc. (NASDAQ:AHPI) from a hold rating to a sell rating in a report released on Monday morning.
Allied Healthcare Products (NASDAQ:AHPI) traded up 3.08% during mid-day trading on Monday, hitting $2.01. The company had a trading volume of 10,569 shares. The company’s market cap is $8.07 million. Allied Healthcare Products has a one year low of $1.53 and a one year high of $3.82. The company’s 50 day moving average price is $2.14 and its 200-day moving average price is $2.13.
TRADEMARK VIOLATION WARNING: This piece was originally reported by Watch List News and is owned by of Watch List News. If you are viewing this piece on another website, it was illegally stolen and reposted in violation of US & international trademark and copyright law. The correct version of this piece can be read at https://www.watchlistnews.com/allied-healthcare-products-inc-ahpi-downgraded-to-sell-at-valuengine/1643740.html.
A hedge fund recently bought a new stake in Allied Healthcare Products stock. Virtu KCG Holdings LLC purchased a new stake in shares of Allied Healthcare Products, Inc. (NASDAQ:AHPI) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 36,950 shares of the medical equipment provider’s stock, valued at approximately $107,000. Virtu KCG Holdings LLC owned approximately 0.92% of Allied Healthcare Products at the end of the most recent quarter. Hedge funds and other institutional investors own 11.05% of the company’s stock.
About Allied Healthcare Products
Allied Healthcare Products, Inc manufactures a range of respiratory products used in the healthcare industry in a range of hospital and alternate site settings, including sub-acute care facilities, home healthcare and emergency medical care. The Company’s respiratory care products are used in the treatment of acute and chronic respiratory disorders such as asthma, emphysema, bronchitis and pneumonia.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Allied Healthcare Products Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allied Healthcare Products Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.